As mutations in USH2A account for 12%–25% of non-syndromic RP patients and for 55%–90% of USH2 patients, it is one of the most important genes in these rare diseases [9,39,40,41]. The gene discussed is USH2A; the disease is retinitis pigmentosa 1.